研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2018 年的期刊文章 · 第 5 页
共 1294 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2018-11-05 到 2018-10-24。
按期刊、按主题看 →
SiM Clinical Trials Causal Inference · 发表于 2018-11-05
Sai Dharmarajan, Joo‐Yeon Lee, Rima Izem
摘要
Case‐crossover study designs are observational studies used to assess postmarket safety of medical products (eg, vaccines or drugs). As a case‐crossover study is self‐controlled, its advantages include better control for confounding because the design controls for any time‐invariant measured and unmeasured confounding and potentially greater feasibility as only data from those experiencing an event (or cases) are required. However, self‐matching also introduces correlation between case and control periods within a subject or matched unit. To estimate sample size in a case‐crossover study, investigators currently use Dupont's formula (Biometrics 1988; 43:1157‐1168), which was originally developed for a matched case‐control study. This formula is relevant as it takes into account correlation in exposure between controls and cases, which are expected to be high in self‐controlled studies. However, in our study, we show that Dupont's formula and other currently used methods to determine sample size for case‐crossover studies may be inadequate. Specifically, these formulas tend to underestimate the true required sample size, determined through simulations, for a range of values in the parameter space. We present mathematical derivations to explain where some currently used methods fail and propose two new sample size estimation methods that provide a more accurate estimate of the true required sample size.
Biometrics Bayesian Methods Nonparametric & Semiparametric Diagnostics & Prediction · 发表于 2018-11-03
Zhen Chen, Beom Seuk Hwang
摘要
In application of diagnostic accuracy, it is possible that a priori information may exist regarding the test score distributions, either between different disease populations for a single test or between multiple correlated tests. Few have considered constrained diagnostic accuracy analysis when the true disease status is binary; almost none when the disease status is ordinal. Motivated by a study on diagnosing endometriosis, we propose an approach to estimating diagnostic accuracy measures that can incorporate different stochastic order constraints on the test scores when an ordinal true disease status is in consideration. We show that the Dirichlet process mixture provides a convenient framework to both flexibly model the test score distributions and embed the a priori ordering constraints. We also utilize the Dirichlet process mixture to model the correlation between multiple tests. In taking a Bayesian perspective to inference, we develop an efficient Markov chain Monte Carlo algorithm to sample from the posterior distribution and provide posterior estimates of the receiver operating characteristic surfaces and the associated summary measures. The proposed approach is evaluated with extensive simulation studies, and is demonstrated with an application to the endometriosis study.
Biometrics High-Dimensional · 发表于 2018-11-02
Stephen Bates, Robert Tibshirani
摘要
Positive-valued signal data is common in the biological and medical sciences, due to the prevalence of mass spectrometry other imaging techniques. With such data, only the relative intensities of the raw measurements are meaningful. It is desirable to consider models consisting of the log-ratios of all pairs of the raw features, since log-ratios are the simplest meaningful derived features. In this case, however, the dimensionality of the predictor space becomes large, and computationally efficient estimation procedures are required. In this work, we introduce an embedding of the log-ratio parameter space into a space of much lower dimension and use this representation to develop an efficient penalized fitting procedure. This procedure serves as the foundation for a two-step fitting procedure that combines a convex filtering step with a second non-convex pruning step to yield highly sparse solutions. On a cancer proteomics data set, the proposed method fits a highly sparse model consisting of features of known biological relevance while greatly improving upon the predictive accuracy of less interpretable methods.
Biometrics Testing & Uncertainty Genetics & Omics · 发表于 2018-11-02
Xiaoyu Dai, Nan Lin, Daofeng Li, Ting Wang
摘要
In the analysis of next-generation sequencing technology, massive discrete data are generated from short read counts with varying biological coverage. Conducting conditional hypothesis testing such as Fisher's Exact Test at every genomic region of interest thus leads to a heterogeneous multiple discrete testing problem. However, most existing multiple testing procedures for controlling the false discovery rate (FDR) assume that test statistics are continuous and become conservative for discrete tests. To overcome the conservativeness, in this article, we propose a novel multiple testing procedure for better FDR control on heterogeneous discrete tests. Our procedure makes decisions based on the marginal critical function (MCF) of randomized tests, which enables achieving a powerful and non-randomized multiple testing procedure. We provide upper bounds of the positive FDR (pFDR) and the positive false non-discovery rate (pFNR) corresponding to our procedure. We also prove that the set of detections made by our method contains every detection made by a naive application of the widely-used q-value method. We further demonstrate the improvement of our method over other existing multiple testing procedures by simulations and a real example of differentially methylated region (DMR) detection using whole-genome bisulfite sequencing (WGBS) data.
SMMR Clinical Trials · 发表于 2018-10-31
Yaoguo Xie, Zhengjun Zhang, Paul J Rathouz, Bruce P Barrett
摘要
Semi-continuous data, also known as zero-inflated continuous data, have a substantial portion of responses equal to a single value (typically 0) and a continuous, right-skewed distribution among the remaining positive values. For jointly modeling multivariate clustered semi-continuous responses, the covariate effects in the positive parts can be proportionally constrained to the covariate effects in the logistic part, yielding a multivariate two-part fixed effects model. It is shown that, both theoretically and experimentally, the proportionally constrained model is more efficient than the unconstrained model in terms of parameter estimation, and thus provides a deeper understanding of the data structure when the proportionality structure holds. A robust variance estimation method is also introduced and tested under various model mis-specified cases. The proposed model is applied to data from a randomized controlled trial evaluating potential preventive effects of meditation or exercise on duration and severity of acute respiratory infection illness. The new analysis infers that meditation not only has highly significant effects on reduction of acute respiratory infection severity and duration, but also has significant effects on preventing acute respiratory infection, which was not previously reported in the literature.
SMMR Longitudinal Data Survival Analysis · 发表于 2018-10-31
Samuel L Brilleman, Michael J Crowther, Margarita Moreno-Betancur, Jacqueline Buros Novik, James Dunyak, Nidal Al-Huniti, Robert Fox, Jeff Hammerbacher, Rory Wolfe
摘要
Joint modelling of longitudinal and time-to-event data has received much attention recently. Increasingly, extensions to standard joint modelling approaches are being proposed to handle complex data structures commonly encountered in applied research. In this paper, we propose a joint model for hierarchical longitudinal and time-to-event data. Our motivating application explores the association between tumor burden and progression-free survival in non-small cell lung cancer patients. We define tumor burden as a function of the sizes of target lesions clustered within a patient. Since a patient may have more than one lesion, and each lesion is tracked over time, the data have a three-level hierarchical structure: repeated measurements taken at time points (level 1) clustered within lesions (level 2) within patients (level 3). We jointly model the lesion-specific longitudinal trajectories and patient-specific risk of death or disease progression by specifying novel association structures that combine information across lower level clusters (e.g. lesions) into patient-level summaries (e.g. tumor burden). We provide user-friendly software for fitting the model under a Bayesian framework. Lastly, we discuss alternative situations in which additional clustering factor(s) occur at a level higher in the hierarchy than the patient-level, since this has implications for the model formulation.
SMMR Other · 发表于 2018-10-31
Lyvia Biagi, Arthur Bertachi, Marga Giménez, Ignacio Conget, Jorge Bondia, Josep Antoni Martín-Fernández, Josep Vehí
摘要
The aim of this study was to apply a methodology based on compositional data analysis (CoDA) to categorise glucose profiles obtained from continuous glucose monitoring systems. The methodology proposed considers complete daily glucose profiles obtained from six patients with type 1 diabetes (T1D) who had their glucose monitored for eight weeks. The glucose profiles were distributed into the time spent in six different ranges. The time in one day is finite and limited to 24 h, and the times spent in each of these different ranges are co-dependent and carry only relative information; therefore, CoDA is applied to these profiles. A K-means algorithm was applied to the coordinates obtained from the CoDA to obtain different patterns of days for each patient. Groups of days with relatively high time in the hypo and/or hyperglycaemic ranges and with different glucose variability were observed. Using CoDA of time in different ranges, individual glucose profiles were categorised into groups of days, which can be used by physicians to detect the different conditions of patients and personalise patient's insulin therapy according to each group. This approach can be useful to assist physicians and patients in managing the day-to-day variability that hinders glycaemic control.
SMMR Causal Inference · 发表于 2018-10-31
Arman Alam Siddique, Mireille E Schnitzer, Asma Bahamyirou, Guanbo Wang, Timothy H Holtz, Giovanni B Migliori, Giovanni Sotgiu, Neel R Gandhi, Mario H Vargas, Dick Menzies, Andrea Benedetti
摘要
This paper investigates different approaches for causal estimation under multiple concurrent medications. Our parameter of interest is the marginal mean counterfactual outcome under different combinations of medications. We explore parametric and non-parametric methods to estimate the generalized propensity score. We then apply three causal estimation approaches (inverse probability of treatment weighting, propensity score adjustment, and targeted maximum likelihood estimation) to estimate the causal parameter of interest. Focusing on the estimation of the expected outcome under the most prevalent regimens, we compare the results obtained using these methods in a simulation study with four potentially concurrent medications. We perform a second simulation study in which some combinations of medications may occur rarely or not occur at all in the dataset. Finally, we apply the methods explored to contrast the probability of patient treatment success for the most prevalent regimens of antimicrobial agents for patients with multidrug-resistant pulmonary tuberculosis.
SiM Causal Inference · 发表于 2018-10-30
Joan Heck Wortman, Jerome P. Reiter
摘要
We develop methodology for causal inference in observational studies when using propensity score subclassification on data constructed with probabilistic record linkage techniques. We focus on scenarios where covariates and binary treatment assignments are in one file and outcomes are in another file, and the goal is to estimate an additive treatment effect by merging the files. We assume that the files can be linked using variables common to both files, eg, names or birth dates, but that links are subject to errors, eg, due to reporting errors in the linking variables. We develop methodology for cases where such reporting errors are independent of the other variables on the files. We describe conceptually how linkage errors can affect causal estimates in subclassification contexts. We also present and evaluate several algorithms for deciding which record pairs to use in estimation of causal effects. Using simulation studies, we demonstrate that case selection procedures can result in improved accuracy in estimates of treatment effects from linked data compared to using only cases known to be true links.
SiM Longitudinal Data Missing Data & Measurement Error · 发表于 2018-10-30
Paul S. Albert
摘要
Shared random parameter models (SRPMs) were first introduced by researchers at the National Heart Lung and Blood Institute (NHLBI) Biostatistics Branch for analyzing longitudinal data with informative dropout (Wu and Carroll, 1987; Wu and Bailey, 1988; Follmann and Wu, 1995; Albert and Follmann, 2000; Albert et al, 2002). This work was all focused on characterizing the longitudinal data process in the presence of an informative missing data mechanism that is treated as a nuisance. Shared random parameter modeling approaches have also been developed from the perspective of characterizing the relationship between longitudinal data and a subsequent outcome that may be an event time, a dichotomous measurement, or another longitudinal outcome. This article will review the early contributions of the NHLBI biostatisticians on SRPMs for analyzing longitudinal data with dropout and demonstrate how these ideas have, more recently, been applied in these other areas of biostatistics. Rather than focus on technical details or specific analyses, this article presents a conceptual framework for SRPMs within a historical context.
SMMR Clinical Trials · 发表于 2018-10-30
Xiaoyin F Fan, Paul Gallo, Guoqin Su, Ronald Menton, Florencia Segal
摘要
In the clinical development of some new infectious disease drugs, early clinical pharmacology trials may predict with high confidence that the efficacious doses are well below the range of the safety margin. In this case, a dose-ranging study may be unnecessary after a proof-of-concept (PoC) study testing the highest dose. A multi-stage adaptive design spanning both PoC and confirmatory stages is proposed in this context. The design incorporates two interim analyses allowing strategies for stopping, continuing, or expanding the study. A conditional power threshold for a binary endpoint is proposed to assess futility. Additional components of early efficacy and sample size adjustment are also included to enhance the design's flexibility and robustness. Design operating characteristics are evaluated by numerical calculation. We show that the proposed streamlined trial design has the same statistical rigor as a conventional phase 3 clinical trial with adequate power and a properly controlled type 1 error rate. Additional adaptive design options are also investigated and discussed.
JASA Other · 发表于 2018-10-29
J. C. Escanciano, S. C. Goh
摘要
Regression quantiles have asymptotic variances that depend on the conditional densities of the response variable given regressors. This article develops a new estimate of the asymptotic variance of regression quantiles that leads any resulting Wald-type test or confidence region to behave as well in large samples as its infeasible counterpart in which the true conditional response densities are embedded. We give explicit guidance on implementing the new variance estimator to control adaptively the size of any resulting Wald-type test. Monte Carlo evidence indicates the potential of our approach to deliver powerful tests of heterogeneity of quantile treatment effects in covariates with good size performance over different quantile levels, data-generating processes, and sample sizes. We also include an empirical example. Supplementary material is available online. *(abstract via OpenAlex)*
JASA Optimization & Learning Theory Causal Inference High-Dimensional · 发表于 2018-10-29
Wensheng Zhu, Donglin Zeng, Rui Song
摘要
Dynamic treatment regimes are a set of decision rules and each treatment decision is tailored over time according to patients' responses to previous treatments as well as covariate history. There is a growing interest in development of correct statistical inference for optimal dynamic treatment regimes to handle the challenges of non-regularity problems in the presence of non-respondents who have zero-treatment effects, especially when the dimension of the tailoring variables is high. In this paper, we propose a high-dimensional Q-learning (HQ-learning) to facilitate the inference of optimal values and parameters. The proposed method allows us to simultaneously estimate the optimal dynamic treatment regimes and select the important variables that truly contribute to the individual reward. At the same time, hard thresholding is introduced in the method to eliminate the effects of the non-respondents. The asymptotic properties for the parameter estimators as well as the estimated optimal value function are then established by adjusting the bias due to thresholding. Both simulation studies and real data analysis demonstrate satisfactory performance for obtaining the proper inference for the value function for the optimal dynamic treatment regimes. *(abstract via PubMed)*
JASA Causal Inference · 发表于 2018-10-29
Yifei Wang, Daniel J. Tancredi, Diana L. Miglioretti
摘要
It is a common interest in medicine to determine whether a hospital meets a benchmark created from an aggregate reference population, after accounting for differences in distributions of multiple covariates. Due to the difficulties of collecting individual-level data, however, it is often the case that only marginal distributions of the covariates are available, making covariate-adjusted comparison challenging. We propose and evaluate a novel approach for conducting indirect standardization when only marginal covariate distributions of the studied hospital are known, but complete information is available for the reference hospitals. We do this with the aid of two existing methods: iterative proportional fit, which estimates the cells of a contingency table when only marginal sums are known, and synthetic control methods, which create a counterfactual control group using a weighted combination of potential control groups. The proper application of these existing methods for indirect standardization would require accounting for the statistical uncertainties induced by a situation where no individual-level data is collected from the studied population. We address this need with a novel method which uses a random Dirichlet parametrization of the synthetic control weights to estimate uncertainty intervals for the standard incidence ratio. We demonstrate our novel methods by estimating hospital-level standardized incidence ratios for comparing the adjusted probability of computed tomography examinations with high radiations doses, relative to a reference standard and we evalauate out methods in a simulation study. *(abstract via PubMed)*
JASA Other · 发表于 2018-10-29
Abdelaati Daouia, Irène Gijbels, Gilles Stupfler
摘要
Quantiles and expectiles of a distribution are found to be useful descriptors of its tail in the same way as the median and mean are related to its central behavior. This article considers a valuable alternative class to expectiles, called extremiles, which parallels the class of quantiles and includes the family of expected minima and expected maxima. The new class is motivated via several angles, which reveals its specific merits and strengths. Extremiles suggest better capability of fitting both location and spread in data points and provide an appropriate theory that better displays the interesting features of long-tailed distributions. We discuss their estimation in the range of the data and beyond the sample maximum. A number of motivating examples are given to illustrate the utility of estimated extremiles in modeling noncentral behavior. There is in particular an interesting connection with coherent measures of risk protection. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
SiM Causal Inference Bayesian Methods · 发表于 2018-10-29
Yu‐Bo Wang, Zhen Chen, Jill M. Goldstein, Germaine M. Buck Louis, Stephen E. Gilman
摘要
Mediation analysis assesses the effect of study exposures on an outcome both through and around specific mediators. While mediation analysis involving multiple mediators has been addressed in recent literature, the case of multiple exposures has received little attention. With the presence of multiple exposures, we consider regularizations that allow simultaneous effect selection and estimation while stabilizing model fit and accounting for model selection uncertainty. In the framework of linear structural‐equation models, we analytically show that a two‐stage approach regularizing regression coefficients does not guarantee a unimodal posterior distribution and that a product‐of‐coefficient approach regularizing direct and indirect effects tends to penalize excessively. We propose a regularized difference‐of‐coefficient approach that bypasses these limitations. Using the connection between regularizations and Bayesian hierarchical models with Laplace prior, we develop an efficient Markov chain Monte Carlo algorithm for posterior estimation and inference. Through simulations, we show that the proposed approach has better empirical performances compared to some alternatives. The methodology is illustrated using data from two epidemiological studies in human reproduction.
SiM Clinical Trials · 发表于 2018-10-28
Mimi Kim, Cuiling Wang, Xiaonan Xue
摘要
In noninferiority (NI) trials, an ongoing methodological challenge is how to handle in the analysis the subjects who are nonadherent to their assigned treatment. Some investigators perform the intent‐to‐treat (ITT) as the primary analysis and the per‐protocol (PP) analysis as sensitivity analysis, whereas others do the reverse since ITT results may be anticonservative in the NI setting. But even when there is agreement between the ITT and PP approaches, NI of the experimental therapy to the comparator is not guaranteed. We propose that a tipping point method be used to further assess the impact of nonadherence on the results of a NI trial. In this approach, data from the nonadherers obtained after treatment discontinuation is not used, and their outcomes under the counterfactual situation of complete adherence are considered missing. The tipping point analysis indicates how sensitive the NI trial results are to the values of these missing counterfactual outcomes. The advantages of this approach are that a model or mechanism for the missing outcomes does not have to be assumed, and all subjects who were randomized are included in the analysis. We consider both binary and continuous outcomes and propose extensions to accommodate different types of nonadherence. The methods are illustrated with examples from two NI trials, one to evaluate different doses of radiation therapy to treat painful bone metastases and the other to compare treatments for reducing depression in adolescents.
JASA High-Dimensional · 发表于 2018-10-26
Wei Qian, Shanshan Ding, R. Dennis Cook
摘要
Sufficient dimension reduction (SDR) is known to be a powerful tool for achieving data reduction and data visualization in regression and classification problems. In this work, we study ultrahigh-dimensional SDR problems and propose solutions under a unified minimum discrepancy approach with regularization. When p grows exponentially with n, consistency results in both central subspace estimation and variable selection are established simultaneously for important SDR methods, including sliced inverse regression (SIR), principal fitted component (PFC), and sliced average variance estimation (SAVE). Special sparse structures of large predictor or error covariance are also considered for potentially better performance. In addition, the proposed approach is equipped with a new algorithm to efficiently solve the regularized objective functions and a new data-driven procedure to determine structural dimension and tuning parameters, without the need to invert a large covariance matrix. Simulations and a real data analysis are offered to demonstrate the promise of our proposal in ultrahigh-dimensional settings. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
Biometrics Bayesian Methods Nonparametric & Semiparametric Latent Variables & Mixtures · 发表于 2018-10-26
Apurva Bhingare, Debajyoti Sinha, Debdeep Pati, Dipankar Bandyopadhyay, Stuart R. Lipsitz
摘要
For many real-life studies with skewed multivariate responses, the level of skewness and association structure assumptions are essential for evaluating the covariate effects on the response and its predictive distribution. We present a novel semiparametric multivariate model and associated Bayesian analysis for multivariate skewed responses. Similar to multivariate Gaussian densities, this multivariate model is closed under marginalization, allows a wide class of multivariate associations, and has meaningful physical interpretations of skewness levels and covariate effects on the marginal density. Other desirable properties of our model include the Markov Chain Monte Carlo computation through available statistical software, and the assurance of consistent Bayesian estimates of the parameters and the nonparametric error density under a set of plausible prior assumptions. We illustrate the practical advantages of our methods over existing alternatives via simulation studies and the analysis of a clinical study on periodontal disease.
JASA Spatial & Time Series · 发表于 2018-10-26
Shanika L. Wickramasuriya, George Athanasopoulos, Rob J. Hyndman
摘要
Large collections of time series often have aggregation constraints due to product or geographical groupings. The forecasts for the most disaggregated series are usually required to add-up exactly to the forecasts of the aggregated series, a constraint we refer to as “coherence.” Forecast reconciliation is the process of adjusting forecasts to make them coherent.The reconciliation algorithm proposed by Hyndman et al. (2011 Hyndman, R. J., Ahmed, R. A., Athanasopoulos, G., and Shang, H. L. (2011), “Optimal Combination Forecasts for Hierarchical Time Series,” Computational Statistics and Data Analysis, 55, 2579–2589.[Crossref], [Web of Science ®] , [Google Scholar]) is based on a generalized least squares estimator that requires an estimate of the covariance matrix of the coherency errors (i.e., the errors that arise due to incoherence). We show that this matrix is impossible to estimate in practice due to identifiability conditions.We propose a new forecast reconciliation approach that incorporates the information from a full covariance matrix of forecast errors in obtaining a set of coherent forecasts. Our approach minimizes the mean squared error of the coherent forecasts across the entire collection of time series under the assumption of unbiasedness. The minimization problem has a closed-form solution. We make this solution scalable by providing a computationally efficient representation.We evaluate the performance of the proposed method compared to alternative methods using a series of simulation designs which take into account various features of the collected time series. This is followed by an empirical application using Australian domestic tourism data. The results indicate that the proposed method works well with artificial and real data. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
JASA Testing & Uncertainty · 发表于 2018-10-26
Qingyuan Zhao, Dylan S. Small, Weijie Su
摘要
In the evaluation of treatment effects, it is of major policy interest to know if the treatment is beneficial for some and harmful for others, a phenomenon known as qualitative interaction. We formulate this question as a multiple testing problem with many conservative null p-values, in which the classical multiple testing methods may lose power substantially. We propose a simple technique—conditioning—to improve the power. A crucial assumption we need is uniform conservativeness, meaning for any conservative p-value p, the conditional distribution (p/τ) | p ⩽ τ is stochastically larger than the uniform distribution on (0, 1) for any τ. We show this property holds for one-sided tests in a one-dimensional exponential family (e.g., testing for qualitative interaction) as well as testing |μ| ⩽ η using a statistic Y ∼ N(μ, 1) (e.g., testing for practical importance with threshold η). We propose an adaptive method to select the threshold τ. Our theoretical and simulation results suggest that the proposed tests gain significant power when many p-values are uniformly conservative and lose little power when no p-value is uniformly conservative. We apply our method to two educational intervention datasets. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
JASA Survival Analysis Nonparametric & Semiparametric Bayesian Methods · 发表于 2018-10-26
Li Li, Alejandro Jara, María José García-Zattera, Timothy E. Hanson
摘要
Motivated by data gathered in an oral health study, we propose a Bayesian nonparametric approach for population-averaged modeling of correlated time-to-event data, when the responses can only be determined to lie in an interval obtained from a sequence of examination times and the determination of the occurrence of the event is subject to misclassification. The joint model for the true, unobserved time-to-event data is defined semiparametrically; proportional hazards, proportional odds, and accelerated failure time (proportional quantiles) are all fit and compared. The baseline distribution is modeled as a flexible tailfree prior. The joint model is completed by considering a parametric copula function. A general misclassification model is discussed in detail, considering the possibility that different examiners were involved in the assessment of the occurrence of the events for a given subject across time. We provide empirical evidence that the model can be used to estimate the underlying time-to-event distribution and the misclassification parameters without any external information about the latter parameters. We also illustrate the effect on the statistical inferences of neglecting the presence of misclassification. *(abstract via PubMed)*
JASA Nonparametric & Semiparametric Testing & Uncertainty Functional Data · 发表于 2018-10-26
Yakuan Chen, Jeff Goldsmith, R. Todd Ogden
摘要
One application of positron emission tomography (PET), a nuclear imaging technique, in neuroscience involves in vivo estimation of the density of various proteins (often, neuroreceptors) in the brain. PET scanning begins with the injection of a radiolabeled tracer that binds preferentially to the target protein; tracer molecules are then continuously delivered to the brain via the bloodstream. By detecting the radioactive decay of the tracer over time, dynamic PET data are constructed to reflect the concentration of the target protein in the brain at each time. The fundamental problem in the analysis of dynamic PET data involves estimating the impulse response function (IRF), which is necessary for describing the binding behavior of the injected radiotracer. Virtually all existing methods have three common aspects: summarizing the entire IRF with a single scalar measure; modeling each subject separately; and the imposition of parametric restrictions on the IRF. In contrast, we propose a functional data analytic approach that regards each subject's IRF as the basic analysis unit, models multiple subjects simultaneously, and estimates the IRF nonparametrically. We pose our model as a linear mixed effect model in which population level fixed effects and subject-specific random effects are expanded using a B-spline basis. Shrinkage and roughness penalties are incorporated in the model to enforce identifiability and smoothness of the estimated curves, respectively, while monotonicity and non-negativity constraints impose biological information on estimates. We illustrate this approach by applying it to clinical PET data with subjects belonging to three diagnosic groups. We explore differences among groups by means of pointwise confidence intervals of the estimated mean curves based on bootstrap samples. *(abstract via PubMed)*
JASA Spatial & Time Series · 发表于 2018-10-26
Anna Louise Schröder, Hernando Ombao
摘要
The goal in this article is to develop a practical tool that identifies changes in the brain activity as recorded in electroencephalograms (EEG). Our method is devised to detect possibly subtle disruptions in normal brain functioning that precede the onset of an epileptic seizure. Moreover, it is able to capture the evolution of seizure spread from one region (or channel) to another. The proposed frequency-specific change-point detection method (FreSpeD) deploys a cumulative sum-type test statistic within a binary segmentation algorithm. We demonstrate the theoretical properties of FreSpeD and show its robustness to parameter choice and advantages against two competing methods. Furthermore, the FreSpeD method produces directly interpretable output. When applied to epileptic seizure EEG data, FreSpeD identifies the correct brain region as the focal point of seizure and the timing of the seizure onset. Moreover, FreSpeD detects changes in cross-coherence immediately before seizure onset which indicate an evolution leading up to the seizure. These changes are subtle and were not captured by the methods that previously analyzed the same EEG data. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
JASA Other · 发表于 2018-10-26
Lixia Hu, Tao Huang, Jinhong You
摘要
The additive model and the varying-coefficient model are both powerful regression tools, with wide practical applications. However, our empirical study on a financial data has shown that both of these models have drawbacks when applied to locally stationary time series. For the analysis of functional data, Zhang and Wang have proposed a flexible regression method, called the varying-coefficient additive model (VCAM), and presented a two-step spline estimation method. Motivated by their approach, we adopt the VCAM to characterize the time-varying regression function in a locally stationary context. We propose a three-step spline estimation method and show its consistency and asymptotic normality. For the purpose of model diagnosis, we suggest an L2-distance test statistic to check multiplicative assumption, and raise a two-stage penalty procedure to identify the additive terms and the varying-coefficient terms provided that the VCAM is applicable. We also present the asymptotic distribution of the proposed test statistics and demonstrate the consistency of the two-stage model identification procedure. Simulation studies investigating the finite-sample performance of the estimation and model diagnosis methods confirm the validity of our asymptotic theory. The financial data are also considered. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
JASA High-Dimensional · 发表于 2018-10-26
Yuqing Pan, Qing Mai, Xin Zhang
摘要
In contemporary scientific research, it is often of great interest to predict a categorical response based on a high-dimensional tensor (i.e., multi-dimensional array) and additional covariates. Motivated by applications in science and engineering, we propose a comprehensive and interpretable discriminant analysis model, called the CATCH model (short for covariate-adjusted tensor classification in high-dimensions). The CATCH model efficiently integrates the covariates and the tensor to predict the categorical outcome. It also jointly explains the complicated relationships among the covariates, the tensor predictor, and the categorical response. The tensor structure is used to achieve easy interpretation and accurate prediction. To tackle the new computational and statistical challenges arising from the intimidating tensor dimensions, we propose a penalized approach to select a subset of the tensor predictor entries that affect classification after adjustment for the covariates. An efficient algorithm is developed to take advantage of the tensor structure in the penalized estimation. Theoretical results confirm that the proposed method achieves variable selection and prediction consistency, even when the tensor dimension is much larger than the sample size. The superior performance of our method over existing methods is demonstrated in extensive simulated and real data examples. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
JASA Bayesian Methods · 发表于 2018-10-26
Steffen Ventz, Matteo Cellamare, Sergio Bacallado, Lorenzo Trippa
摘要
Most Bayesian response-adaptive designs unbalance randomization rates toward the most promising arms with the goal of increasing the number of positive treatment outcomes during the study, even though the primary aim of the trial is different. We discuss Bayesian uncertainty directed designs (BUD), a class of Bayesian designs in which the investigator specifies an information measure tailored to the experiment. All decisions during the trial are selected to optimize the available information at the end of the study. The approach can be applied to several designs, ranging from early stage multi-arm trials to biomarker-driven and multi-endpoint studies. We discuss the asymptotic limit of the patient allocation proportion to treatments, and illustrate the finite-sample operating characteristics of BUD designs through examples, including multi-arm trials, biomarker-stratified trials, and trials with multiple co-primary endpoints. Supplementary materials for this article, including a standardized description of the materials available for reproducing the work, are available as an online supplement. *(abstract via OpenAlex)*
Biometrics Machine Learning Causal Inference Testing & Uncertainty · 发表于 2018-10-26
Xinlei Mi, Fei Zou, Ruoqing Zhu
摘要
An ENsemble Deep Learning Optimal Treatment (EndLot) approach is proposed for personalized medicine problems. The statistical framework of the proposed method is based on the outcome weighted learning (OWL) framework which transforms the optimal decision rule problem into a weighted classification problem. We further employ an ensemble of deep neural networks (DNNs) to learn the optimal decision rule. Utilizing the flexibility of DNNs and the stability of bootstrap aggregation, the proposed method achieves a considerable improvement over existing methods. An R package “ITRlearn” is developed to implement the proposed method. Numerical performance is demonstrated via simulation studies and a real data analysis of the Cancer Cell Line Encyclopedia data.
Biometrics Clinical Trials Survival Analysis Optimization & Learning Theory · 发表于 2018-10-26
Andrew G. Chapple, Peter F. Thall
摘要
Conventionally, evaluation of a new drug, A, is done in three phases. Phase I is based on toxicity to determine a “maximum tolerable dose” (MTD) of A, phase II is conducted to decide whether A at the MTD is promising in terms of response probability, and if so a large randomized phase III trial is conducted to compare A to a control treatment, usually based on survival time or progression free survival time. It is widely recognized that this paradigm has many flaws. A recent approach combines the first two phases by conducting a phase I-II trial, which chooses an optimal dose based on both efficacy and toxicity, and evaluation of A at the selected optimal phase I-II dose then is done in a phase III trial. This paper proposes a new design paradigm, motivated by the possibility that the optimal phase I-II dose may not maximize mean survival time with A. We propose a hybridized design, which we call phase I-II/III, that combines phase I-II and phase III by allowing the chosen optimal phase I-II dose of A to be re-optimized based on survival time data from phase I-II patients and the first portion of phase III. The phase I-II/III design uses adaptive randomization in phase I-II, and relies on a mixture model for the survival time distribution as a function of efficacy, toxicity, and dose. A simulation study is presented to evaluate the phase I-II/III design and compare it to the usual approach that does not re-optimize the dose of A in phase III.
SiM Bayesian Methods Clinical Trials · 发表于 2018-10-25
Akalu Banbeta, Joost van Rosmalen, David Dejardin, Emmanuel Lesaffre
摘要
Including historical data may increase the power of the analysis of a current clinical trial and reduce the sample size of the study. Recently, several Bayesian methods for incorporating historical data have been proposed. One of the methods consists of specifying a so‐called power prior whereby the historical likelihood is downweighted with a weight parameter. When the weight parameter is also estimated from the data, the modified power prior (MPP) is needed. This method has been used primarily when a single historical trial is available. We have adapted the MPP for incorporating multiple historical control arms into a current clinical trial, each with a separate weight parameter. Three priors for the weights are considered: (1) independent, (2) dependent, and (3) robustified dependent. The latter is developed to account for the possibility of a conflict between the historical data and the current data. We analyze two real‐life data sets and perform simulation studies to compare the performance of competing Bayesian methods that allow to incorporate historical control patients in the analysis of a current trial. The dependent power prior borrows more information from comparable historical studies and thereby can improve the statistical power. Robustifying the dependent power prior seems to protect against prior‐data conflict.
Biometrics Longitudinal Data Missing Data & Measurement Error · 发表于 2018-10-25
Christos Thomadakis, Loukia Meligkotsidou, Nikos Pantazis, Giota Touloumi
摘要
Missing data are common in longitudinal studies. Likelihood-based methods ignoring the missingness mechanism are unbiased provided missingness is at random (MAR); under not-at-random missingness (MNAR), joint modeling is commonly used, often as part of sensitivity analyses. In our motivating example of modeling CD4 count trajectories during untreated HIV infection, CD4 counts are mainly censored due to treatment initiation, with the nature of this mechanism remaining debatable. Here, we evaluate the bias in the disease progression marker's change over time (slope) of a specific class of joint models, termed shared-random-effects-models (SREMs), under MAR drop-out and propose an alternative SREM model. Our proposed model relates drop-out to both the observed marker's data and the corresponding random effects, in contrast to most SREMs, which assume that the marker and the drop-out processes are independent given the random effects. We analytically calculate the asymptotic bias in two SREMs under specific MAR drop-out mechanisms, showing that the bias in marker's slope increases as the drop-out probability increases. The performance of the proposed model, and other commonly used SREMs, is evaluated under specific MAR and MNAR scenarios through simulation studies. Under MAR, the proposed model yields nearly unbiased slope estimates, whereas the other SREMs yield seriously biased estimates. Under MNAR, the proposed model estimates are approximately unbiased, whereas those from the other SREMs are moderately to heavily biased, depending on the parameterization used. The examined models are also fitted to real data and results are compared/discussed in the light of our analytical and simulation-based findings.
Biometrics Causal Inference Survival Analysis Nonparametric & Semiparametric · 发表于 2018-10-25
Jared D. Huling, Menggang Yu, A. James O'Malley
摘要
Randomized controlled trials are the gold standard for estimating causal effects of treatments or interventions, but in many cases are too costly, too difficult, or even unethical to conduct. Hence, many pressing medical questions can only be investigated using observational studies. However, direct statistical modeling of observational data can result in biased estimates of treatment effects due to unmeasured confounding. In certain cases, instrumental variable based techniques can be used to remove such biases. These techniques are indeed widely studied and used in econometrics under parametric outcome models, however limited works have focused on the utilization of instrumental variables in survival analysis, where semiparametric models are often necessary. The additional challenge in analyzing survival data is the presence of censoring. In this paper, we introduce an instrumental variable method that relaxes the strong assumptions of previous works and provides consistent estimation of the causal effect of a treatment on a survival outcome. We demonstrate the efficacy of our method in various simulated settings and an analysis of Medicare enrollment data comparing two prevalent surgical procedures for abdominal aortic aneurysm from an observational study.
SiM Clinical Trials Bayesian Methods · 发表于 2018-10-25
Chenguang Wang, Gary L. Rosner, Richard B.S. Roden
摘要
Phase I clinical trials are the first step in drug development to test a new drug or drug combination on humans. Typical designs of Phase I trials use toxicity as the primary endpoint and aim to find the maximum tolerable dosage. However, these designs are poorly applicable for the development of cancer therapeutic vaccines because the expected safety concerns for these vaccines are not as much as cytotoxic agents. The primary objectives of a cancer therapeutic vaccine phase I trial thus often include determining whether the vaccine shows biologic activity and the minimum dose necessary to achieve a full immune or even clinical response. In this paper, we propose a new Bayesian phase I trial design that allows simultaneous evaluation of safety and immunogenicity outcomes. We demonstrate the proposed clinical trial design by both a numeric study and a therapeutic human papillomavirus vaccine trial.
SiM Clinical Trials Diagnostics & Prediction Survival Analysis · 发表于 2018-10-24
Richard D Riley, Kym IE Snell, Joie Ensor, Danielle L Burke, Frank E Harrell Jr, Karel GM Moons, Gary S Collins
摘要
When designing a study to develop a new prediction model with binary or time‐to‐event outcomes, researchers should ensure their sample size is adequate in terms of the number of participants ( n ) and outcome events ( E ) relative to the number of predictor parameters ( p ) considered for inclusion. We propose that the minimum values of n and E (and subsequently the minimum number of events per predictor parameter, EPP) should be calculated to meet the following three criteria: (i) small optimism in predictor effect estimates as defined by a global shrinkage factor of ≥ 0.9, (ii) small absolute difference of ≤ 0.05 in the model's apparent and adjusted Nagelkerke's R 2 , and (iii) precise estimation of the overall risk in the population. Criteria (i) and (ii) aim to reduce overfitting conditional on a chosen p , and require prespecification of the model's anticipated Cox‐Snell R 2 , which we show can be obtained from previous studies. The values of n and E that meet all three criteria provides the minimum sample size required for model development. Upon application of our approach, a new diagnostic model for Chagas disease requires an EPP of at least 4.8 and a new prognostic model for recurrent venous thromboembolism requires an EPP of at least 23. This reinforces why rules of thumb (eg, 10 EPP) should be avoided. Researchers might additionally ensure the sample size gives precise estimates of key predictor effects; this is especially important when key categorical predictors have few events in some categories, as this may substantially increase the numbers required.
Biometrics Other · 发表于 2018-10-24
Christopher R. Bilder, Joshua M. Tebbs, Christopher S. McMahan
摘要
Infectious disease testing frequently takes advantage of two tools—group testing and multiplex assays—to make testing timely and cost effective. Until the work of Tebbs et al. (2013) and Hou et al. (2017), there was no research available to understand how best to apply these tools simultaneously. This recent work focused on applications where each individual is considered to be identical in terms of the probability of disease. However, risk-factor information, such as past behavior and presence of symptoms, is very often available on each individual to allow one to estimate individual-specific probabilities. The purpose of our paper is to propose the first group testing algorithms for multiplex assays that take advantage of individual risk-factor information as expressed by these probabilities. We show that our methods significantly reduce the number of tests required while preserving accuracy. Throughout this paper, we focus on applying our methods with the Aptima Combo 2 Assay that is used worldwide for chlamydia and gonorrhea screening.
SMMR Networks & Graphs · 发表于 2018-10-24
Monia Lupparelli
摘要
In linear regression modelling, the distortion of effects after marginalizing over variables of the conditioning set has been widely studied in several contexts. For Gaussian variables, the relationship between marginal and partial regression coefficients is well established and the issue is often addressed as a result of W. G. Cochran. Possible generalizations beyond the linear Gaussian case have been developed, nevertheless the case of discrete variables is still challenging, in particular in medical and social science settings. A multivariate regression framework is proposed for binary data with regression coefficients given by the logarithm of relative risks, and a multivariate Relative Risk formula is derived to define the relationship between marginal and conditional relative risks. The method is illustrated through the analysis of the morphine data in order to assess the effect of preoperative oral morphine administration on the postoperative pain relief.
Biometrics High-Dimensional Diagnostics & Prediction · 发表于 2018-10-24
Jessica Gronsbell, Jessica Minnier, Sheng Yu, Katherine Liao, Tianxi Cai
摘要
The use of Electronic Health Records (EHR) for translational research can be challenging due to difficulty in extracting accurate disease phenotype data. Historically, EHR algorithms for annotating phenotypes have been either rule-based or trained with billing codes and gold standard labels curated via labor intensive medical chart review. These simplistic algorithms tend to have unpredictable portability across institutions and low accuracy for many disease phenotypes due to imprecise billing codes. Recently, more sophisticated machine learning algorithms have been developed to improve the robustness and accuracy of EHR phenotyping algorithms. These algorithms are typically trained via supervised learning, relating gold standard labels to a wide range of candidate features including billing codes, procedure codes, medication prescriptions and relevant clinical concepts extracted from narrative notes via Natural Language Processing (NLP). However, due to the time intensiveness of gold standard labeling, the size of the training set is often insufficient to build a generalizable algorithm with the large number of candidate features extracted from EHR. To reduce the number of candidate predictors and in turn improve model performance, we present an automated feature selection method based entirely on unlabeled observations. The proposed method generates a comprehensive surrogate for the underlying phenotype with an unsupervised clustering of disease status based on several highly predictive features such as diagnosis codes and mentions of the disease in text fields available in the entire set of EHR data. A sparse regression model is then built with the estimated outcomes and remaining covariates to identify those features most informative of the phenotype of interest. Relying on the results of Li and Duan (1989), we demonstrate that variable selection for the underlying phenotype model can be achieved by fitting the surrogate-based model. We explore the performance of our methods in numerical simulations and present the results of a prediction model for Rheumatoid Arthritis (RA) built on a large EHR data mart from the Partners Health System consisting of billing codes and NLP terms. Empirical results suggest that our procedure reduces the number of gold-standard labels necessary for phenotyping thereby harnessing the automated power of EHR data and improving efficiency.